Literature DB >> 9167965

Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group.

A Angeli1, G Osella, A Alì, M Terzolo.   

Abstract

BACKGROUND: The incidental discovery of an adrenal mass raises the problem of distinguishing the frequent benign masses from the infrequent malignant ones that require surgery. At present, univocal guidelines to approach this problem are not available. The aim of the present study was to perform a multicentric retrospective analysis of adrenal masses incidentally discovered (adrenal incidentalomas). PATIENTS AND METHODS: Hospital records of adrenal incidentalomas diagnosed over a 15-year period in 29 surgical and medical centers in Italy were scrutinized. Collected cases were 1,013, and 887 were analyzed.
RESULTS: The majority of patients were in the 5th and 6th decade and females were predominantly affected. The frequency of adrenocortical cancer was 12% among operated patients (316 cases). The tumor diameter was highly correlated with the risk of malignancy, as well as the CT characteristics such as density, shape and margins. The frequency of pheochromocytoma was 10% among operated patients.
CONCLUSIONS: The occurrence of incidentally discovered adrenocortical carcinomas and pheochromocytomas is not rare. Evaluation of the mass size and CT characteristics are simple and effective methods to differentiate malignant lesions. Biochemical screening for pheochromocytoma is mandatory before surgery.

Entities:  

Mesh:

Year:  1997        PMID: 9167965     DOI: 10.1159/000185477

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  46 in total

1.  Bilateral primary adrenal non-Hodgkin's lymphoma without adrenal insufficiency.

Authors:  William Greg Simpson; Paurush Babbar; Lynnetta Faith Payne
Journal:  Urol Ann       Date:  2015 Apr-Jun

2.  Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas.

Authors:  Kenji Oki; Kiminori Yamane; Yu Sakashita; Nozomu Kamei; Hiroshi Watanabe; Naoyuki Toyota; Masanobu Shigeta; Hironobu Sasano; Nobuoki Kohno
Journal:  Clin Exp Nephrol       Date:  2008-06-10       Impact factor: 2.801

3.  Disappearing adrenal masses.

Authors:  I G Hermsen; M P J Polak; H R Haak
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

4.  Guidelines for the management of the incidentally discovered adrenal mass.

Authors:  Anil Kapoor; Topher Morris; Ryan Rebello
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

5.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

6.  [Incidental findings in abdominal ultrasound. Characteristics and clinical interpretation].

Authors:  C Görg; S Kunsch; A Neesse
Journal:  Internist (Berl)       Date:  2014-09       Impact factor: 0.743

Review 7.  Adrenal Teratoma: a Case Series and Review of the Literature.

Authors:  Eric J Kuo; Anthony E Sisk; Zhiming Yang; Jiaoti Huang; Michael W Yeh; Masha J Livhits
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

8.  Primary adrenal lymphoma with initial presentation concerning for bilateral adrenal pheochromocytomas.

Authors:  Flavian Grace Joseph; Sheila Cook; Durgesh Gowda
Journal:  BMJ Case Rep       Date:  2017-08-22

9.  1,161 patients with adrenal incidentalomas: indications for surgery.

Authors:  A A Kasperlik-Załuska; M Otto; A Cichocki; E Rosłonowska; J Słowinska-Srzednicka; W Zgliczyński; W Jeske; L Papierska; T Tołłoczko; J Polański; R Słapa
Journal:  Langenbecks Arch Surg       Date:  2007-11-10       Impact factor: 3.445

10.  Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.

Authors:  J Waldmann; G Feldmann; E P Slater; P Langer; M Buchholz; A Ramaswamy; W Saeger; M Rothmund; V Fendrich
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.